IP Library › Granted Patent US 9,957,558
Granted Patent B2
US 9,957,558 · App. 13/458,739 · Granted May 1, 2018

Methods and compositions for multiplex PCR

Inventors: John Leamon (Guilford, CT); Mark Andersen (Carlsbad, CA); Michael Thornton (San Francisco, CA)
Assignee: LIFE TECHNOLOGIES CORPORATION
C12Q1/686C12N15/1065C12Q1/6806C12Q1/6855C12Q1/6874C12Q1/6886C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,957,558
App. No.
13/458,739
Filed
Apr 27, 2012
Granted
May 1, 2018
Kind
B2
Art Unit
1637
USPC
435/6.12
Abstract

The present invention provides methods, compositions, kits, systems and apparatus that are useful for multiplex PCR of one or more nucleic acids present in a sample. In particular, various target-specific primers are provided that allow for the selective amplification of one or more target sequences. In one aspect, the invention relates to target-specific primers useful for the selective amplification of one or more target sequences associated with cancer or inherited disease. In some aspects, amplified target sequences obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing and used to detect the presence of genetic variants.

Claims (24)

1. A method for preparing a library of different target sequences from a sample, comprising:

amplifying within a single amplification reaction mixture a multiplex of different target sequences from a sample including a plurality of different target sequences,

wherein the amplifying includes contacting at least some portion of the sample with a plurality of target-specific primers, and a polymerase under amplification conditions, thereby producing a multiplex of different amplified target sequences, wherein at least one of the plurality of target-specific primers and at least one of the produced multiplex of different amplified target sequences includes a cleavable group;

cleaving the cleavable group of at least one of the multiplex of different amplified target sequences and forming a cleaved end; and

ligating at least one adapter to a cleaved end of at least one of the multiplex of different amplified target sequences, thereby producing one or more adapter-ligated amplified target sequences;

thereby preparing a library of different adapter-ligated target sequences, wherein the number of different target-specific sequences amplified during the single multiplex amplification reaction is about 12-plex to about 10000 different target sequences, and

wherein none of the adapters in the ligation reaction hybridizes under high stringency conditions to any one of the multiplex of different amplified target sequences.

2. The method of claim 1 , wherein one or more of the at least one adapter is not completely complementary to at least one amplified target sequence.

3. The method of claim 1 , wherein at least one of the one or more adapters is less than 15% complementary along its length to at least one amplified target sequence.

4. The method of claim 1 , wherein each of the plurality of target-specific primers has any one or more of the following criteria: (1) includes two or more modified nucleotides within the primer sequence, at least one of which is included near or at the termini of the primer and at least one of which is included at, or about the center nucleotide position of the primer sequence; (2) length is about 15 to about 40 bases in length; (3) T m is from about 60° C. to about 70° C.; (4) has low cross-reactivity with non-target sequences present in the sample; (5) at least the first four nucleotides (going from 3′ to 5′ direction) are non-complementary to any sequence within any other primer present in the reaction; and (6) are non-complementary to any consecutive stretch of at least 5 nucleotides within any other produced amplified target sequence.

5. The method of claim 1 , wherein a adapter that is ligated to at least one of the plurality of different amplified target sequences is susceptible to exonuclease digestion.

6. The method of claim 1 , wherein a adapter that is ligated to at least one of the plurality of different amplified target sequences does not include a protecting group.

7. The method of claim 1 , wherein prior to the ligating at least one of the multiplex of different amplified target sequences is phosphorylated at the 5′ end.

8. The method of claim 1 , wherein the ligating includes contacting at least one of the multiplex of different amplified target sequences with a ligation reaction mixture including one or more adapters and a ligase under ligation conditions, wherein the ligation reaction mixture does not include one or more additional oligonucleotides prior to ligating the one or more adapters to at least one of the plurality of different amplified target sequences.

9. The method of claim 1 , wherein the method further includes a phosphorylating step prior to the ligating, thereby producing at least one-different amplified target sequence possessing a 5′ phosphate group.

10. The method of claim 1 , wherein the ligating includes an isothermal ligation reaction.

11. The method of claim 1 , wherein the ligation reaction includes no more than two different adapters.

12. The method of claim 1 , wherein the plurality of different target sequences is no less than twenty four different target sequences.

13. The method of claim 1 , wherein the plurality of different target sequences is no greater than 6144 different target sequences.

14. The method of claim 2 , wherein the at least one adapter does not include a sequence that is completely complementary to the 3′ end or the 5′ end of the plurality of different amplified target sequences.

15. The method of claim 1 , wherein the 3′ end or the 5′ end of the plurality of different amplified target sequences includes a cleavable group within about 15 terminal nucleotides.

16. The method of claim 1 , wherein the method further includes reamplifying at least one of the adapter-ligated amplified target sequences.

17. The method of claim 1 , further comprising combining two or more libraries each separately prepared in a single reaction, thereby preparing a library of different adapter-ligated target sequences.

18. The method of claim 1 , wherein the steps of amplifying, cleaving, ligating and preparing the library are carried out in a singles reaction vessel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2012
From: LEAMON, JOHN; ANDERSEN, MARK; THORNTON, MICHAEL
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 028404/0399 →
Continuity (12)
Provisional Application 61479952 · Apr 28, 2011
Provisional Application 61531583 · Sep 6, 2011
Provisional Application 61531574 · Sep 6, 2011
Provisional Application 61538079 · Sep 22, 2011
Provisional Application 61564763 · Nov 29, 2011
Provisional Application 61578192 · Dec 20, 2011
Provisional Application 61594160 · Feb 2, 2012
Provisional Application 61598881 · Feb 14, 2012
Provisional Application 61598892 · Feb 14, 2012
Provisional Application 61625596 · Apr 17, 2012
Provisional Application 61639017 · Apr 26, 2012
Related Publication 20120295819A1 · Nov 22, 2012